| Letter Number | Subject | Date Added to Website |
|---|---|---|
| 2024-16 | RE: Reimbursement for Provider Preventable Conditions Update | 7/25/24 |
| 2024-15 | RE: Hospital Provision Emergency Opioid Antagonist | 7/25/24 |
| 2024-14 | RE: Taxonomy Compliance Edits | 6/27/24 |
| 2024-13 | RE: Prior Authorization of Aliqopa® – Effective July 1, 2024 | 5/24/24 |
| 2024-12 | RE: Certified Registered Nurse Anesthetists Coding and Billing | 5/24/24 |
| 2024-11 | RE: SoonerSelect Dental Process Revisions | 5/24/24 |
| 2024-10 | RE: Psychiatric Collaborative Care Model Reimbursement | 5/22/24 |
| 2024-09 | RE: PDMP Compliance Survey | 5/16/24 |
| 2024-08 | RE: Human Immunodeficiency Virus (HIV) Counseling (OK SPA 23-0032) | 5/8/24 |
| 2024-07 | RE: Prior Authorization of Kepivance™ – Effective May 6, 2024 | 4/5/24 |
| 2024-06 | RE: Prior Authorization of Cerezyme®, ELELYSO®, VPRIV® and ELAPRASE® – Effective April 15, 2024 | 3/19/24 |
| 2024-05 | RE: SoonerSelect and SoonerSelect Children’s Specialty Program Implementation April 1, 2024 | 3/15/24 |
| 2024-04 | RE: Yearly Compliance with the Deficit Reduction Act of 2005 – FFY 2023 | 1/18/24 |
| 2024-03 | RE: Skilled Nursing Facility Site Visit | 1/16/24 |
| 2024-02 | RE: SoonerSelect Dental Provider Updates | 1/4/24 |
| 2024-01 | RE: Provider Credentialing Interim Process | 1/4/24 |
Archived
Provider Letters
Last Modified on
Jul 25, 2024
